This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| EMBL Course Programme | |
|---|---|
| Name | EMBL Course Programme |
| Formation | 1978 |
| Headquarters | Heidelberg |
| Leader title | Director |
| Parent organization | European Molecular Biology Laboratory |
EMBL Course Programme The EMBL Course Programme is a flagship training initiative of the European Molecular Biology Laboratory providing advanced practical and theoretical training in molecular biology and related life sciences. It links researchers from institutions such as Max Planck Society, Wellcome Trust Sanger Institute, Institut Pasteur, Francis Crick Institute, and Karolinska Institutet through short courses, workshops, and summers schools. The programme complements long-term research at centres including European Bioinformatics Institute, EMBL Grenoble, EMBL Hamburg, and EMBL Barcelona while interacting with funding and policy bodies like European Research Council, Horizon 2020, and Human Frontier Science Program.
The programme operates across EMBL sites in Heidelberg, Grenoble, Hamburg', and Barcelona, and collaborates with partners such as Universität Heidelberg, University of Cambridge, University of Oxford, ETH Zurich, Utrecht University, University of Copenhagen, Ecole Normale Supérieure, University of Milan, University of Geneva, Karlsruhe Institute of Technology, Imperial College London, University of Manchester, University College London, Danish Technical University, CNRS, CERN, Max Delbrück Center for Molecular Medicine, EMBL-EBI, Copenhagen University Hospital, Novartis, BioMed X, Institut Curie, University of Barcelona, Barcelona Supercomputing Center, Leibniz Association, Friedrich Miescher Institute and other institutes across Europe and beyond. Course themes are shaped by breakthroughs from laboratories such as Wellcome Trust Sanger Institute and companies like Illumina and Thermo Fisher Scientific, and by initiatives including ELIXIR, Global Alliance for Genomics and Health, FAIR principles, and Open Science movements.
Since EMBL’s foundation in 1974 under leaders linked to institutions like Max Planck Society and EMBO, the Course Programme expanded under directors associated with European Molecular Biology Organization, EMBL Grenoble founders, and collaborators from University of Freiburg and Karolinska Institutet. Early training events drew participants from labs such as MRC Laboratory of Molecular Biology, Cold Spring Harbor Laboratory, Salk Institute, Stanford University School of Medicine, Harvard Medical School, and University of California, San Francisco. Programmatic evolution reflected technological revolutions—impacting work at Sanger Institute, Institut Pasteur, ETH Zurich and prompting partnerships with funders including Wellcome Trust and Gatsby Charitable Foundation.
EMBL Course Programme provides practical courses, theoretical workshops, and online resources, developed with partners including European Bioinformatics Institute, ELIXIR, EMBL-EBI, EMBL units, Wellcome Sanger Institute, Max Planck Institute for Molecular Genetics, Francis Crick Institute, Institut Pasteur, Karolinska Institutet, CNRS labs, University of Cambridge Department of Biochemistry, Imperial College London Department of Life Sciences, ETH Zurich Department of Biology, University of Oxford Department of Biochemistry, University College London Department of Genetics, Evolution and Environment, Leibniz Institute DSMZ, European Molecular Biology Organization, Human Frontier Science Program, EMBO Course Network, European Research Council, ELIXIR Spain, Swiss National Science Foundation, European Molecular Biology Laboratory, Barcelona Supercomputing Center, Francis Crick Institute Training Hub, Wellcome Centre for Human Genetics, Max Delbrück Center, Friedrich Miescher Institute for Biomedical Research, CERN openlab, EMBL-EBI Training, Genome Research Limited, Institut Curie training, Danish National Research Foundation, Novartis Institutes for BioMedical Research, Pfizer Research, GSK Research, Illumina Academy, Thermo Fisher Academy.
Applicants historically come from universities and institutes such as University of Lisbon, Hebrew University of Jerusalem, University of Cape Town, University of São Paulo, University of Tokyo, Peking University, Tsinghua University, Seoul National University, National University of Singapore, Monash University, University of Melbourne, McGill University, University of Toronto, Yale School of Medicine, Columbia University Irving Medical Center, Johns Hopkins University School of Medicine, University of Chicago, Princeton University, ETH Zurich, Karolinska Institutet, Imperial College London, University of Cambridge, University of Oxford, and numerous national research centers funded by entities such as European Research Council, Wellcome Trust, NIH, DFG, ANR, ERC Starting Grants and philanthropic foundations like Gordon and Betty Moore Foundation and Wallenberg Foundation. Selection panels often include faculty from EMBL-EBI, Francis Crick Institute, Max Planck Institutes, Institute of Cancer Research, Institut Pasteur, and industrial partners like Illumina.
Typical curricula balance hands-on laboratory modules with computational training in tools from Bioconductor, Galaxy Project, TensorFlow applications in imaging, and workflows centered on platforms developed at EMBL-EBI, European Genome-phenome Archive, ArrayExpress, Ensembl, UniProt, Pfam, InterPro, PDB, GitHub collaborations, and cloud resources like Amazon Web Services used by research groups at European Bioinformatics Institute and Barcelona Supercomputing Center. Practical modules mirror methods from notable labs such as Francis Crick Institute cell biology groups, MRC Laboratory of Molecular Biology structural biology, Sanger Institute genomics, Cold Spring Harbor Laboratory genetics, and Whitehead Institute systems biology. Courses integrate protocols and standards promoted by FAIR principles, Global Alliance for Genomics and Health, and repositories like Zenodo.
Alumni include researchers who progressed to positions at institutions like Max Planck Institute for Developmental Biology, European Molecular Biology Laboratory, Wellcome Trust Sanger Institute, Institut Pasteur, Francis Crick Institute, University of Cambridge, University of Oxford, ETH Zurich, Karolinska Institutet, Imperial College London, Harvard Medical School, MIT, Stanford University, Columbia University, Yale University, Johns Hopkins University, University of California, San Francisco, Cold Spring Harbor Laboratory, and biotech firms such as Genentech, Gilead Sciences, Roche, Novartis, Pfizer, Merck Group, Illumina, Thermo Fisher Scientific, Sartorius, Qiagen, Bio-Rad Laboratories, and startups spun out via incubators like BioMed X.
The programme influences research networks linking EMBL-EBI with consortia including ELIXIR, European Open Science Cloud, Global Alliance for Genomics and Health, Human Cell Atlas, ENCODE Project Consortium, 1000 Genomes Project, and collaborative projects with Wellcome Trust Sanger Institute, Max Planck Society, Institut Pasteur, Francis Crick Institute, Karolinska Institutet, CNRS, CERN, Barcelona Supercomputing Center, European Research Council, Horizon Europe programmes, and industrial partnerships with Illumina, Thermo Fisher Scientific, Roche Diagnostics, Novartis, and EMBO. Its methods training has underpinned research outputs cited alongside major works from MRC Laboratory of Molecular Biology, Cold Spring Harbor Laboratory, Salk Institute, Whitehead Institute, Broad Institute, and repositories such as PubMed Central and Europe PMC.